查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1453903

2030 年肺動脈瓣置換市場預測：按瓣膜類型、手術類型、應用、最終用戶和地區進行的全球分析

Pulmonary Valve Replacement Market Forecasts to 2030 - Global Analysis By Valve Type, Procedure Type, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球肺動脈瓣置換市場規模為 12 億美元，預計在預測期內年複合成長率為 7.1%，到 2030 年將達到 20 億美元。

肺動脈瓣置換術（PVR）是一種旨在替換心臟中有缺陷或損壞的肺動脈瓣的外科手術。肺動脈瓣調節從心臟右心室流向肺動脈的血流，促進肺部血液氧合。外科醫生通常使用機械或生物人工瓣膜來恢復正常的心臟功能。 PVR 可緩解呼吸急促、胸痛和疲勞等症狀，改善整體心臟健康和生活品質。術後護理包括監測併發症和心臟康復，以支持康復和長期健康。

醫療保健支出增加

隨著醫療保健支出的增加，特別是在新興經濟體和已開發國家，獲得專業心臟護理的機會也在增加。這些基礎設施的改進將使醫療保健提供者能夠為更多患者提供更廣泛的治療選擇。此外，醫療保健支出的增加通常與保險覆蓋範圍和報銷政策的改善有關，從而減少患者的財務障礙。

高成本

手術的複雜性和侵入性是導致肺動脈瓣置換術高成本的兩個主要因素。這些因素影響手術的總成本，包括術前評估、術後照護和後續觀察。此外，用於肺動脈瓣置換的材料（例如人工瓣膜和導管）可能很昂貴，這進一步增加了手術成本。

技術進步

人工瓣膜設計和材料的進步有助於提高肺動脈瓣置換術的壽命、耐用性和生物相容性。這些創新帶來更好的臨床結果並降低瓣膜關閉不全率，從而提高患者滿意度並減少再次手術的需要。此外，3D 超音波心動圖和心臟磁振造影(MRI) 等影像技術的進步正在增強術前規劃並推動該市場的成長。

缺乏意識

對肺動脈瓣疾病的症狀和後果認知不足可能會延誤診斷和干涉，導致患者預後不良。醫療保健提供者也缺乏對技術和工藝最新進展的透徹了解，這可能導致患者護理不佳和適當治療方法的利用不足。此外，患者及其家人可能對外科手術有誤解和恐懼，這可能會阻礙市場規模。

COVID-19 的影響

COVID-19 的爆發對肺動脈瓣置換市場產生了重大影響。隨著世界各地的醫療系統投入資源對抗這場流行病，包括肺動脈瓣置換術在內的選擇性手術被推遲或取消。這導致專門從事心臟介入治療的製造商和醫療機構的手術數量和收益下降。此外，患者因擔心接觸病毒而不願尋求非緊急護理，進一步減少了肺動脈瓣置換術的需求。

組織工程肺動脈瓣領域預計在預測期內成為最大

據估計，組織工程肺動脈瓣段佔最大佔有率。這些瓣膜旨在模仿天然肺動脈瓣的結構和功能，為肺動脈瓣功能障礙患者提供了一個有前景的解決方案。組織工程肺動脈瓣通常是透過將細胞接種到生物分解性的支架上來製造，從而允許生物組織生長。此外，組織工程瓣膜在長期功能和動態性能方面顯示出可喜的結果，逐漸推動了該領域的成長。

經導管肺動脈瓣置換術（TPVR）領域預計在預測期內年複合成長率最高

經導管肺動脈瓣置換術（TPVR）領域預計在預測期內年複合成長率最高，因為它是一種使用導管治療的微創肺動脈瓣置換術。這種方法對於患有先天性心臟病、肺動脈瓣狹窄和逆流的患者特別有益。此外，與傳統的外科手術相比，TPVR 手術在安全性、有效性和患者復健方面顯示出優異的結果，這正在推動這一領域的擴張。

比最大的地區

由於先天性心臟疾病和瓣膜性心臟病的盛行率不斷增加，北美在估計期間佔據了最大的市場佔有率。該地區是Medtronic)、雅培實驗室 (Abbott Laboratories) 和波士頓科學 (Boston Scientific) 等大公司的所在地。此外，旨在改善心血管保健和促進醫學研究的政府措施也在推動市場成長方面發揮重要作用。

年複合成長率最高的地區：

由於醫療技術的顯著進步和健全的醫療保健系統，預計歐洲在預測期內的年複合成長率最高。德國、法國、英國和義大利等國家對該地區的市場成長做出了重大貢獻。此外，歐洲擁有強大的法律規範，支持醫療創新、確保新型肺動脈瓣置換技術的安全性和有效性、促進競爭並促進該領域的進步。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球肺動脈瓣置換市場：依瓣膜類型

  • 組織工程肺動脈瓣
  • 生物人工肺瓣膜
  • 同種異體肺動脈瓣
  • 機械性肺動脈瓣
  • 其他閥門類型

第6章全球肺動脈瓣置換市場：依手術類型

  • 經導管肺動脈瓣置換術（TPVR）
  • 肺動脈瓣置換術（心臟直視手術）
  • 機器人輔助肺動脈瓣置換術
  • 羅斯手術
  • 瓣膜切開術
  • 其他治療類型

第7章全球肺動脈瓣置換市場：依應用分類

  • 肺動脈狹窄
  • 瓣膜功能障礙
  • 先天性心臟缺陷
  • 肺逆流
  • 其他用途

第8章全球肺動脈瓣置換市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 心臟專科診所
  • 其他最終用戶

第9章全球肺動脈瓣置換市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Edwards Lifesciences
  • Medtronic
  • Terumo Corporation
  • CryoLife, Inc
  • SynCardia Systems, Inc.
  • Abbott Laboratories
  • Merit Medical Systems
  • LivaNova PLC
  • Micro Interventional Devices, Inc.
  • Boston Scientific
  • Braile Biomedica
  • JenaValve Technology, Inc.
  • B. Braun Melsungen AG
  • Medistim
  • CardioMech AS
Product Code: SMRC25455

According to Stratistics MRC, the Global Pulmonary Valve Replacement Market is accounted for $1.2 billion in 2023 and is expected to reach $2.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Pulmonary valve replacement (PVR) is a surgical procedure aimed at replacing a defective or damaged pulmonary valve in the heart. The pulmonary valve regulates blood flow from the heart's right ventricle to the pulmonary artery, facilitating oxygenation of blood in the lungs. Surgeons typically use either mechanical or biological prosthetic valves to restore proper cardiac function. PVR can alleviate symptoms like shortness of breath, chest pain, and fatigue, improving overall heart health and quality of life. Post-operative care involves monitoring for complications and cardiac rehabilitation to support recovery and long-term well-being.

Market Dynamics:

Driver:

Increasing healthcare expenditure

As healthcare spending rises, particularly in emerging economies and developed countries, there is a corresponding increase in access to specialized cardiac care procedures. This improved infrastructure enables healthcare providers to offer a wider range of treatment options to a greater number of patients. Moreover, increased healthcare spending often correlates with improvements in insurance coverage and reimbursement policies, reducing financial barriers for patients, which drives this market growth.

Restraint:

High cost

The complexity and invasiveness of the procedure are two of the primary factors contributing to the high cost of pulmonary valve replacement. These factors contribute to the overall cost of the procedure, including pre-operative assessments, post-operative care, and follow-up visits. Additionally, the materials used in pulmonary valve replacement, such as prosthetic valves or conduits, can be expensive, further driving up the cost of the procedure.

Opportunity:

Technological advancements

Advancements in prosthetic valve design and materials contribute to improved longevity, durability, and biocompatibility of pulmonary valve replacements. These innovations result in better clinical outcomes and reduced rates of valve failure, leading to increased patient satisfaction and a decreased need for repeat interventions. Furthermore, advancements in imaging technologies, such as 3D echocardiography and cardiac magnetic resonance imaging (MRI), enhance preoperative planning, which is boosting this market growth.

Threat:

Lack of awareness

Limited awareness about the symptoms and consequences of pulmonary valve conditions may lead to delays in diagnosis and intervention, resulting in poorer patient outcomes. Healthcare providers may also lack sufficient understanding of the latest advancements in techniques and technologies, leading to suboptimal patient care and the underutilization of appropriate treatments. Furthermore, patients and their families may have misconceptions or fears about surgical procedures, which can impede this market size.

Covid-19 Impact

The COVID-19 pandemic has significantly impacted the pulmonary valve replacement market. As healthcare systems worldwide diverted resources to manage the pandemic, elective procedures, including pulmonary valve replacements, experienced delays and cancellations. This led to a reduction in procedural volumes and revenue for manufacturers and healthcare facilities specializing in cardiac interventions. Moreover, patient reluctance to seek non-urgent medical care due to fear of exposure to the virus further dampened demand for pulmonary valve replacement procedures.

The tissue engineered pulmonary valves segment is expected to be the largest during the forecast period

The tissue engineered pulmonary valves segment is estimated to hold the largest share. These valves are designed to mimic the structure and function of native pulmonary valves, offering promising solutions for patients with pulmonary valve dysfunction. Tissue-engineered pulmonary valves are typically created by seeding cells onto a biodegradable scaffold, allowing for the growth of living tissue. Additionally, tissue-engineered valves have shown promising outcomes in terms of long-term functionality and hemodynamic performance, which gradually boosts this segment's growth.

The transcatheter pulmonary valve replacement (TPVR) segment is expected to have the highest CAGR during the forecast period

The transcatheter pulmonary valve replacement (TPVR) segment is anticipated to have highest CAGR during the forecast period due to its minimally invasive procedure for replacing pulmonary valves via catheterization. This approach is particularly beneficial for patients with congenital heart defects, pulmonary valve stenosis, or regurgitation. Furthermore, TPVR procedures have demonstrated excellent outcomes in terms of safety, efficacy, and patient recovery, compared to traditional surgical interventions, which are driving this segment's expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to a growing prevalence of congenital heart diseases and valve disorders. This region is home to some of the major players, such as Medtronic, Abbott Laboratories, and Boston Scientific. Moreover, government initiatives aimed at improving cardiovascular healthcare and advancing medical research also play a vital role in fueling market growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to significant advancements in medical technology, robust healthcare systems. Countries like Germany, France, the United Kingdom, and Italy are key contributors to the market's growth in the region. Additionally, Europe has a strong regulatory framework supporting medical innovation, ensuring the safety and efficacy of new pulmonary valve replacement technologies, fostering competition, and driving advancements in the field.

Key players in the market

Some of the key players in the Pulmonary Valve Replacement Market include Edwards Lifesciences, Medtronic, Terumo Corporation, CryoLife, Inc, SynCardia Systems, Inc., Abbott Laboratories, Merit Medical Systems, LivaNova PLC, Micro Interventional Devices, Inc., Boston Scientific, Braile Biomedica, JenaValve Technology, Inc., B. Braun Melsungen AG, Medistim and CardioMech AS.

Key Developments:

In January 2024, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.

In December 2023, Medtronic plc announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral(TM) renal denervation (RDN) system, also known as the Symplicity(TM) blood pressure procedure, for the treatment of hypertension.

In September 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX(TM) Pro Left Atrial Appendage Closure (LAAC) Device.

Valve Types Covered:

  • Tissue Engineered Pulmonary Valves
  • Bioprosthetic Pulmonary Valves
  • Homograft Pulmonary Valves
  • Mechanical Pulmonary Valves
  • Other Valve Types

Procedure Types Covered:

  • Transcatheter Pulmonary Valve Replacement (TPVR)
  • Surgical Pulmonary Valve Replacement (Open-heart surgery)
  • Robotic-Assisted Pulmonary Valve Replacement
  • Ross Procedure
  • Valvulotomy
  • Other Procedure Types

Applications Covered:

  • Pulmonary Stenosis
  • Valve Dysfunction
  • Congenital Heart Defects
  • Pulmonary Regurgitation
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Cardiac Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pulmonary Valve Replacement Market, By Valve Type

  • 5.1 Introduction
  • 5.2 Tissue Engineered Pulmonary Valves
  • 5.3 Bioprosthetic Pulmonary Valves
  • 5.4 Homograft Pulmonary Valves
  • 5.5 Mechanical Pulmonary Valves
  • 5.6 Other Valve Types

6 Global Pulmonary Valve Replacement Market, By Procedure Type

  • 6.1 Introduction
  • 6.2 Transcatheter Pulmonary Valve Replacement (TPVR)
  • 6.3 Surgical Pulmonary Valve Replacement (Open-heart surgery)
  • 6.4 Robotic-Assisted Pulmonary Valve Replacement
  • 6.5 Ross Procedure
  • 6.6 Valvulotomy
  • 6.7 Other Procedure Types

7 Global Pulmonary Valve Replacement Market, By Application

  • 7.1 Introduction
  • 7.2 Pulmonary Stenosis
  • 7.3 Valve Dysfunction
  • 7.4 Congenital Heart Defects
  • 7.5 Pulmonary Regurgitation
  • 7.6 Other Applications

8 Global Pulmonary Valve Replacement Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Cardiac Specialty Clinics
  • 8.5 Other End Users

9 Global Pulmonary Valve Replacement Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Edwards Lifesciences
  • 11.2 Medtronic
  • 11.3 Terumo Corporation
  • 11.4 CryoLife, Inc
  • 11.5 SynCardia Systems, Inc.
  • 11.6 Abbott Laboratories
  • 11.7 Merit Medical Systems
  • 11.8 LivaNova PLC
  • 11.9 Micro Interventional Devices, Inc.
  • 11.10 Boston Scientific
  • 11.11 Braile Biomedica
  • 11.12 JenaValve Technology, Inc.
  • 11.13 B. Braun Melsungen AG
  • 11.14 Medistim
  • 11.15 CardioMech AS

List of Tables

  • Table 1 Global Pulmonary Valve Replacement Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 3 Global Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 4 Global Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 5 Global Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 6 Global Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 7 Global Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 8 Global Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 9 Global Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 10 Global Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 11 Global Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 12 Global Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 13 Global Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 14 Global Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 15 Global Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 17 Global Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 18 Global Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 19 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 20 Global Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 Global Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 23 Global Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 Global Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 25 Global Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 26 North America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 27 North America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 28 North America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 29 North America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 30 North America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 31 North America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 32 North America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 33 North America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 34 North America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 35 North America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 36 North America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 37 North America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 38 North America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 39 North America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 40 North America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 42 North America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 43 North America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 44 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 45 North America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 North America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 North America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 48 North America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 49 North America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 50 North America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 51 Europe Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 52 Europe Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 53 Europe Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 54 Europe Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 55 Europe Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 56 Europe Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 57 Europe Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 58 Europe Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 59 Europe Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 60 Europe Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 61 Europe Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 62 Europe Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 63 Europe Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 64 Europe Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 65 Europe Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 66 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 67 Europe Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 68 Europe Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 69 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 70 Europe Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 71 Europe Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 72 Europe Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 73 Europe Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 74 Europe Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 75 Europe Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 76 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 78 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 79 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 80 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 81 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 82 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 83 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 84 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 85 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 86 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 87 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 88 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 89 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 90 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 92 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 93 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 94 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 95 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 96 Asia Pacific Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 98 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 99 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 100 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 South America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 South America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 103 South America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 104 South America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 105 South America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 106 South America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 107 South America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 108 South America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 109 South America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 110 South America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 111 South America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 112 South America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 113 South America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 114 South America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 115 South America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 116 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 117 South America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 118 South America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 119 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 120 South America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 121 South America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 122 South America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 123 South America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 124 South America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 125 South America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 126 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 127 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 128 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 129 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 130 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 131 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 132 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 133 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 134 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 135 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 136 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 137 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 138 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 139 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 141 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 142 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 143 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 144 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 145 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 146 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 147 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 148 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 149 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 150 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)